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Experts have stated that referral for rehabilitation of patients with chronic obstructive
pulmonary disease (COPD) becomes appropriate when these patients become aware of
their disability (e.g. usually grade 3 to 5 on the Medical Research Council (MRC) dyspnea
scale). However, patients with MRC dyspnea grade 1/2 may also suffer from extra-
pulmonary features, such as abnormal body composition, exercise intolerance and reduced
disease-specific health status. In the present study, we have studied whether and to what
extent chronic obstructive pulmonary disease (COPD) patients with MRC dyspnea grade 1/2
have extra-pulmonary features compared to patients with grade 3, 4 or 5?
Pulmonary function, body composition, 6-min walking distance, peak exercise capacity,
anxiety, depression and disease-specific health status have been assessed in 333
outpatients who had been referred for pulmonary rehabilitation. On average, patients
with MRC dyspnea grade 1/2 had a better exercise tolerance and disease-specific health
status compared to patients with grade 4 or 5. Nevertheless, grade 1/2 patients had a
higher prevalence of muscle mass depletion. In addition, these patients did still have
aberrant values in one or more of the aforementioned outcomes.Elsevier Ltd. All rights reserved.
587 600; fax: +31 475 587 592
eion.nl (M.A. Spruit).
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MRC dyspnea grade in COPD 2455On average, patients with MRC dyspnea grade 1/2 may clearly suffer from extra-pulmonary
features, indicating the necessity to refer these patients for rehabilitation. Therefore,
MRC dyspnea scale alone does not appear to be a suitable measure to identify most
patients with COPD who have to be referred for rehabilitation.
& 2007 Elsevier Ltd. All rights reserved.Introduction
Patients with moderate to severe chronic obstructive
pulmonary disease (COPD) may suffer every day from
dyspnea.1,2 The degree of severity of dyspnea perception
and its repercussions on daily functioning have been
assessed regularly in patients with moderate to severe
COPD and have been shown to be worse compared to healthy
age-matched control subjects.3,4
The Medical Research Council (MRC) scale is a
simple measure of dyspnea,4 which has shown to be
more discriminating than staging of disease severity
of the American Thoracic Society with respect to
5-year survival of patients with COPD.5 Furthermore, the
MRC dyspnea scale has been suggested in recent interna-
tional guidelines to identify COPD patients that may
benefit from rehabilitation (e.g. usually grades 3 to 5).6,7
This suggestion has been based on experts opinion that
rehabilitation of patients with COPD becomes appropri-
ate when these patients become aware of their disability,
irrespective of their pulmonary dysfunction.7 In fact, COPD
patients entering rehabilitation with MRC dyspnea grade
3 or above have been shown to have a clear exercise
intolerance, reduced disease-specific health status,
reduced mood status and reduced self-reported daily
physical activity, especially in COPD patients with grade
5.4,8 Unfortunately, Bestall and colleagues did not enroll
COPD patients with MRC dyspnea grade 1/2, given that
these grades correspond to mild disability due to
dyspnea.4 In spite of this, it is still reasonable to hypothesize
that COPD patients with lower MRC dyspnea grades
(grade 1 or 2) can still suffer from extra-pulmonary features
(i.e. exercise capacity, body composition and disease-
specific health status), which may partly improve following
pulmonary rehabilitation.
For instance, a mean 6-min walking distance (6MWD)
of only 71% predicted has been found in COPD patients
entering rehabilitation with MRC dyspnea grade 1/2.9
Moreover, mean body mass index (BMI, body weight (kg)
divided by squared height (m)) tended to be significantly
lower in COPD patients entering pulmonary rehabilitation
with MRC dyspnea grade 1/2 than those of patients with
MRC dyspnea grade 3/4.9 Even though this unexpected
finding was not significant, it is reminiscent for the possible
existence of disparities in body composition after stratifica-
tion for MRC dyspnea grades. Finally, median scores on
the domain symptoms of the St. George’s Respiratory
Questionnaire (SGRQ) in male COPD outpatients with
MRC dyspnea grade 2 were comparable to those of patients
with dyspnea grade 3 or above.10 Actually, the mean
total SGRQ scores of grade 1/2 COPD patients enteringrehabilitation9 were clearly worse than values obtained in
healthy elderly.11
At present, it remains unknown whether and to what
extent extra-pulmonary features are different after strati-
fication for MRC dyspnea grades in a large cohort of
consecutive COPD patients referred for rehabilitation by
their chest physician.Methods
Patients
Pulmonary function, dyspnea, body composition, exercise
capacity, mood status and disease-specific health status
have been assessed prospectively between January 1, 2005
to November 1, 2006 in 333 consecutive patients with
moderate to severe COPD. Additionally, self-reported co-
existing morbidity was assessed using the Charlson comor-
bidity index.12
All patients were admitted to the Centre for Integrated
Rehabilitation of Organ failure (CIRO) to undergo a
3-day intake/assessment program before the start of a
comprehensive interdisciplinary pulmonary rehabilitation
program.
Previously, the use of long-term oxygen therapy has been
shown to be related to hospital admission rate in COPD,13
which, in turn has been shown to clearly affect disease-
specific health status.14 Therefore, patients who were on
long-term oxygen therapy were not included in the present
analyses. All tests were performed in the clinical routine and
were in accordance with World Medical Association declara-
tion of Helsinki.15 All participants were Caucasian and gave
informed consent. The local Medical Ethical Commission
approved this observational study.Assessments
Pulmonary function and arterial blood gases
Forced expiratory volume in the 1 s (FEV1) and forced vital
capacity (FVC) were calculated from the flow–volume curve
using spirometry. FEV1 was also calculated 15min after
inhalation of a b agonist via a metered dose inhaler. Carbon
monoxide transfer factor of the lung (DLCO) was determined
using the single breath method. Lung function parameters
were expressed as a percentage of reference values.16
Arterial oxygen tension (PaO2), arterial carbon dioxide
tension (PaCO2) and arterial oxygen saturation (SaO2) were
analyzed with a blood gas analyzer.
ARTICLE IN PRESS
M.A. Spruit et al.2456Dyspnea
Self-perceived dyspnea in relation to physical disability has
been assessed by using the MRC dyspnea scale.4 COPD
patients had to grade their self-perceived dyspnea by using
pre-defined statements, e.g. (1) ‘‘I only get breathless with
strenuous exercise’’; (2) ‘‘I get short of breath when
hurrying on the level or up a slight hill’’; (3) ‘‘I walk slower
than people of the same age on the level because of
breathlessness or have to stop for breath when walking at
my own pace on the level’’; (4) ‘‘I stop for breath after
walking 100 yards or after a few minutes on the level’’; and
(5) ‘‘I am too breathless to leave the house or breathless
when dressing or undressing’’.
Body composition
Body composition was assessed by using single-frequency
bioelectrical impedance assessment after overnight fast-
ing.17 Fat-free mass was calculated by using validated COPD-
specific equations.18 A priori, a BMI o21 kg/m2 and a fat-
free mass index (FFMI, fat-free mass in kilogram divided by
squared height in meters, f/m) o15/16 kg/m2 have been
defined as abnormally low.17
Exercise capacity
Peak cycling load and peak aerobic capacity (VO2) have been
assessed by using a symptom-limited incremental ergometry
cycling test19 and were normalized for age, sex and height.20
In addition, functional exercise capacity has been assessed
by using a 6MWD test21 and were expressed in percentage
(%) predicted.22
Mood status
Anxiety and depression have been assessed using the
Hospital Anxiety and Depression Scale (HADS). A priori, a
score ofX10 points for anxiety and/or depression had been
defined as abnormally high and may be suggestive for the
presence of clinically relevant symptoms of anxiety and/or
depression.23 Scores can range from 0 ( ¼ optimal) to 21
points ( ¼ worst).
Disease-specific health status
SGRQ has been used to asses disease-specific health status.3
It consists of three domains (symptoms, activity and impact)
and a total score. Scores can range from 0 ( ¼ optimal) to
100 points ( ¼ worst).
Statistics
All statistics were done using GraphPad Prism 4.03 and SPSS
14.0. Obtained values have been tested for normality and
are presented as mean (standard deviation, SD). Patients
were stratified by self-reported MRC dyspnea grades. Due to
the low number of COPD patients with MRC dyspnea grade 1
(n ¼ 9), the authors have decided a posteriori to combine
the results of these patients with those of grade 2.
Differences between MRC strata have been assessed by
using a one-way analysis of variances (ANOVA). In addition,
Fisher’s least significant differences (LSD) test has been used
as post-hoc test because of an unequal group size.
Differences in the prevalence of low BMI or low FFMI
between MRC dyspnea grades (1/2 versus 3, 4, 5, respec-
tively; 3 versus 4 and 5; and 4 versus 5) have been assessedby using Chi square test. A priori, a two-sided level of
significance was set at pp0.05.24
Results
General characteristics
Patients generally had mild to severe COPD (FEV1:
45.9715.0% predicted; FEV1/FVC: 44.1712.9%), normal
arterial blood gases (PaO2: 9.371.2 kPa; PaCO2:
5.370.7 kPa), normal body composition (BMI:
25.175.0 kg/m2; FFMI (f/m): 15.472.0/17.172.1 kg/m2),
functional exercise intolerance (6MWD: 69.7716.3% pre-
dicted), peak exercise intolerance (VO2: 64.5724.5% pre-
dicted; peak cycling load: 56.7722.5% predicted),
normal mood status (anxiety: 6.974.7 points;
depression: 6.974.1 points) and reduced disease-specific
health status (total SGRQ score: 55.0717.0 points). In
addition, patients had a mean MRC dyspnea grade
of 3.671.2.
Stratification by MRC dyspnea grades
Characteristics
Mean age and scores on the Charlson comorbidity index
were not significantly different between MRC dyspnea
grades (Table 1). Patients with MRC dyspnea grade 1/2
had a significantly better FEV1 than patients with grade
3, 4 or 5. In addition, patients with MRC dyspnea grade
3 had a significantly better FEV1 than patients grade 4 or 5.
In contrast, the degree of severity of airway obstruction
was comparable between MRC strata (Table 1). Static
lung hyperinflation was comparable between patients
with MRC dyspnea grade 1/2 or grade 3, but was signifi-
cantly lower compared to patients with grade 4 or 5. DLCO
was comparable between patients with MRC dyspnea
grade 1/2 or grade 3, but was significantly better
compared to patients with grade 4 or 5. Differences in
DLCO disappeared after correction for alveolar surface
(Table 1).
Body composition
Patients with MRC dyspnea grade 4 had a high mean BMI,
which was significantly higher than values obtained in
patients with MRC dyspnea grade 1/2 or grade 3 (Table 2).
Additionally, 27.6% of the patients with MRC dyspnea grade
1/2 had an abnormal low BMI, which tended to be less
prevalent in patients with MRC dyspnea grade 4 (14.8%,
p ¼ 0.086).
On average, FFMI was comparable between the MRC
strata in female and male patients (Table 2). Then again, the
prevalence of an abnormal low FFMI was significantly higher
in the grade 1/2 patients (48.3%) than in grade 4 patients
(27.9%, p ¼ 0.022).
Functional exercise capacity
Functional exercise capacity was clearly reduced in all MRC
strata (Table 2). Nevertheless, patients with MRC dyspnea
grade 1/2 had a significantly better absolute 6MWD than
patients with grade 3, 4 or 5. In addition, grade 3 patients
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Table 1 General characteristics.
Grade 1/2 Grade 3 Grade 4 Grade 5 ANOVA
Male/female 33/25 69/41 33/28 65/39 –
Age, years 62.1 (9.7) 63.9 (9.3) 64.8 (9.7) 64.2 (9.2) 0.4240
Charlson index, points 1.45 (0.80) 1.46 (0.80) 1.59 (0.90) 1.61 (0.99) 0.5035
Pulmonary function
FEV1, % predicted 55.2 (12.7) 48.4 (14.8)
* 42.0 (13.8)*y 39.8 (14.0)*y o0.0001
FEV1/IVC, % 47.4 (11.1) 44.1 (11.1) 44.2 (14.4) 42.0 (14.5) 0.1031
RV/TLC ratio 0.53 (0.09) 0.54 (0.09) 0.60 (0.10)*y 0.61 (0.09)*y o0.0001
DLCO, % predicted 57.2 (18.6) 54.1 (16.7) 47.5 (14.0)*z 48.1 (17.3)*z 0.0020
DLCO/VA, % pred 64.9 (23.2) 64.4 (21.7) 60.5 (20.7) 62.8 (25.4) 0.7353
Arterial blood gases
PaO2, kPa 9.5 (1.2) 9.4 (1.2) 9.2 (1.1) 9.2 (1.3) 0.3452
PaCO2, kPa 5.4 (0.6)
z 5.2 (0.6) 5.4 (0.7)z 5.4 (0.7)z 0.0459
SaO2, % 93.9 (2.5) 93.8 (2.2) 93.4 (2.5) 93.5 (2.8) 0.6540
Values expressed as mean (SD). Forced expiratory volume in the 1 s (FEV1), inspiratory vital capacity (IVC), residual volume (RV), total
lung capacity (TLC), carbon monoxide transfer factor (DLCO), carbon monoxide transfer factor after correction for alveolar surface
(DLCO/VA), resting arterial oxygen tension (PaO2), resting arterial carbon dioxide tension (PaCO2), resting arterial oxygen saturation
(SaO2).
Post-hoc: *pp0.01 Versus grade 1/2.
ypp0.01 versus grade 3;
zpp0.05 versus grade 3.
MRC dyspnea grade in COPD 2457had a better 6MWD than patients with MRC dyspnea grade 4
or 5.
After correction for gender, age, height and body
weight,22 significant differences were found between
patients with grade 1/2 and grade 4 or 5; between patients
with grade 3 and grade 4 or 5; and between patients with
grade 4 and grade 5 (Figure 1).
Changes in transcutaneous oxygen saturation following
the 6MWD test were comparable between the MRC strata, as
well as peak heart rate and symptom Borg score for fatigue
at the end of 6MWD test (Table 2). In contrast, symptom
Borg score for dyspnea at the end of 6MWD test was
significantly lower in patients with grade 1/2 compared to
patients with grade 4 or 5. In addition, patients with MRC
dyspnea grade 3 perceived less breathlessness at the end of
the 6WMD test than patients with grade 5.Peak exercise capacity
Absolute peak cycling load was significantly different
between the MRC strata, except for the difference between
patients with grades 4 and 5. These differences remained
significant after correction for gender, age and height
(Table 2).
Patients with MRC dyspnea grade 1/2 had a significantly
better peak VO2 per kilogram body weight than patients
with grade 3, 4 or 5. Additionally, patients with MRC dyspnea
grade 3 had a significantly better peak VO2 per kilogram
body weight than patients with grade 4 or 5. Conversely,
after expressing peak oxygen uptake as a percentage of the
reference values of Jones and colleagues,20 there were only
significant differences between patients with MRC dyspnea
grade 1/2 and 5; and grades 3 and 5.Peak heart rate was significantly higher in patients with
MRC dyspnea grade 1/2 compared to grade 3, 4 or 5. In
addition, patients with MRC dyspnea grade 3 had signifi-
cantly higher mean peak heart rate compared to patients
with grade 4 or 5.
Patients with MRC dyspnea grade 3 had significantly
higher absolute minute ventilation than patients with grade
4 or 5. In addition, patients with MRC dyspnea grade 1/2 had
significantly higher absolute minute ventilation than pa-
tients with grade 4 or 5. In contrast, patients with MRC
dyspnea grade 4 or 5 had relatively higher minute ventila-
tion than grade 1/2 patients. Symptom Borg scores for
dyspnea and fatigue and changes in transcutaneous
SaO2 were not significantly different between MRC strata
(Table 2).
Mood status
Significant differences in HADS anxiety score were found
between patients with MRC dyspnea grades 3 and 5, and
between grades 4 and 5 (Table 3). Patients with MRC
dyspnea grades 1/2 or 3 had lower ( ¼ better) HADS
depression scores than grade 5 patients. Additionally,
40.7% and 43.5% of the grade 5 patients had an abnormal
high score for anxiety and depression, respectively. The
prevalence of increased HADS scores for anxiety and
depression was lower in patients with grade 1/2 (27.8%,
p ¼ 0.006 and 20.8%, p ¼ 0.118, respectively) or grade 3
(19.6%, p ¼ 0.001 and 23.1%, p ¼ 0.001, respectively).
Disease-specific health status
Significant differences in the three SGRQ domains between
the different MRC strata have resulted in significant
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Table 2 Outcomes of physical fitness.
Grades 1/2 Grade 3 Grade 4 Grade 5 ANOVA
Body composition
BMI, kg/m2 24.1 (4.5) 24.6 (4.1) 26.3 (6.1)#,z 25.5 (5.2) 0.0441
FFMI (f), kg/m2 14.8 (1.4) 15.2 (1.7) 16.0 (2.7) 15.5 (2.0) 0.1557
FFM (m), kg/m2 16.8 (2.0) 17.0 (1.8) 17.7 (2.6) 17.1 (2.2) 0.3104
6MWD
Meters 525.0 (92.5) 492.7 (87.9)# 412.4 (95.8)*y 383.2 (104.3)*y o0.0001
% predicted 80.2 (14.2) 75.9 (13.4) 65.7 (13.6)*y 59.8 (15.4)*y,zz o0.0001
DtSaO2, % 3.4 (4.2) 4.8 (4.6) 4.7 (4.6) 3.7 (4.2) 0.1027
Peak HR, bpm 107.9 (17.6) 109.9 (16.4) 104.7 (16.4) 105.1 (17.7) 0.1254
Dyspnea end 3.4 (1.8) 4.1 (2.1) 4.7 (2.3)* 4.9 (2.2)*y 0.0002
Fatigue end 3.4 (2.2) 3.7 (2.3) 3.9 (2.5) 4.0 (2.4) 0.4800
Cycling test
Peak load, watts 94.3 (29.4) 81.0 (30.2)* 62.5 (34.1)*y 59.4 (26.0)*y o0.0001
Peak load, % pred 73.2 (21.5) 62.8 (21.2)* 46.7 (18.6)*y 46.8 (18.7)*y o0.0001
Peak VO2, ml/min/kg 18.2 (4.4) 16.8 (4.1)
# 14.8 (4.5)*y 13.6 (3.2)*y o0.0001
Peak VO2, % pred 71.0 (24.0) 66.4 (24.4) 64.9 (25.6) 58.4 (23.4)
#,z 0.0135
DtSaO2, % 3.5 (3.3) 3.8 (3.3) 3.1 (3.4) 2.7 (3.0) 0.1019
HR, bpm 138.8 (21.0) 130.4 (23.4)# 120.5 (18.4)*z 122.9 (18.9)*z o0.0001
Peak HR, % max HR 87.0 (11.9) 82.3 (12.2)# 77.6 (10.9)*y 78.9 (11.6)*y o0.0001
Peak VE, l/min 47.1 (13.2) 45.1 (16.0) 39.7 (14.5)*z 38.7 (11.8)*y o0.0001
Peak VE, % MVV 80.8 (17.7) 87.7 (23.8) 92.1 (26.3)# 93.9 (26.4)* 0.0092
Dyspnea end 6.3 (2.2) 6.7 (2.1) 6.5 (1.6) 7.1 (1.6) 0.0506
Fatigue end 5.9 (2.3) 5.1 (2.4) 4.8 (2.2) 5.2 (2.5) 0.0871
Values expressed as mean (SD). Body mass index (BMI), kilogram (kg), squared meter (m2), fat-free mass index (FFMI), female (f), male
(m), oxygen uptake (VO2), transcutaneous oxygen saturation (tSaO2), heart rate (HR), beats per minute (bpm), ventilation (VE),
maximal voluntary ventilation (MVV), liters (l), minute.25
Post-hoc: *pp0.01 versus grade 1/2;
#pp0.05 versus grade 1/2;
ypp0.01 versus grade 3;
zpp0.05 versus grade 3;
zzpp0.01 versus grade 4.
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Figure 1 Functional exercise intolerance.
M.A. Spruit et al.2458differences in SGRQ total scores between all MRC strata
(Table 3). Thus, patients with a lower MRC dyspnea grade
had significantly lower ( ¼ better) SGRQ total scores than
patients with higher MRC dyspnea grades (Figure 2).Discussion
The present study demonstrates significant differences in
extra-pulmonary features in a large cohort of patients with
COPD entering pulmonary rehabilitation after stratification
for MRC dyspnea grades.Body composition
Previously, mean BMI tended to be significantly lower in
COPD patients entering rehabilitation with MRC dyspnea
grade 1/2 (26.3 kg/m2) than those of patients with MRC
dyspnea grade 3/4 (29.2 kg/m2).9 In the present study, grade
4 patients also had a high mean BMI, which was significantly
higher than the normal mean BMI of patients with
MRC dyspnea grade 1/2 or 3 (Table 2). Indeed, a higher
mean BMI may explain to some extent a higher dyspnea
perception in daily life.26,27 Then again, underweight
COPD patients (mean BMI: 18.7 kg/m2) have been shown
to have a significantly worse mean modified MRC dyspnea
grade than normal weight peers (mean BMI: 24.5 kg/m2).28
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Table 3 Mood and health status.
Grades 1/2 Grade 5 ANOVA
HADS (n ¼ 299)
Anxiety, points 6.9 (4.9) 6.0 (4.1) 6.6 (5.2) 8.3 (4.7)y, 0.0064
Depression, points 6.3 (4.0) 6.2 (3.8) 7.0 (4.3) 8.1 (4.3)#,y 0.0098
SGRQ (n ¼ 290)
Symptoms, points 54.6 (20.9) 61.7 (18.5)# 66.5 (21.7)* 71.4 (15.6)*y o0.0001
Activity, points 50.5 (18.1) 64.8 (17.3)* 74.3 (16.5)*y 82.6 (10.4)*y,zz o0.0001
Impact, points 31.0 (17.9) 40.5 (18.4)* 47.0 (16.7)*z 54.7 (15.6)*y,zz o0.0001
Total score, points 40.8 (16.6) 51.3 (15.9)* 58.5 (14.8)*y 65.9 (11.2)*y,zz o0.0001
Values expressed as mean (SD). Hospital Anxiety and Depression Scale (HADS), St. George’s Respiratory Questionnaire (SGRQ).
Post-hoc: *pp0.01 versus grade 1/2;
ypp0.01 versus grade 3;
#pp0.05 versus grade 1/2;
zpp0.05 versus grade 3;
zzpp0.01 versus grade 4;
pp0.05 versus grade 4.
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Figure 2 Disease-specific health status.
MRC dyspnea grade in COPD 2459The present authors were not able to corroborate these
findings.
Even though the mean FFMI was similar amongst the MRC
strata after stratification for gender, 48.3% of the COPD
patients with MRC dyspnea grade 1/2 had an abnormal low
FFMI, which may partly be related to daily physical inactivity
in patients with COPD.29 This suggests the possible existence
of a reduced daily physical activity level in a subgroup of
COPD patients with MRC dyspnea grade 1/2. Indeed,
patients may modify their daily behavior (e.g. less weight-
bearing activities and/or a lower effort patients may exert
in completing activities of daily life) to avoid unpleasant
sensations of dyspnea.30 In fact, an a posteriori analysis has
been shown that grade 1/2 patients with a normal FFMI
tended to have a higher FEV1 than grade 1/2 patients with
an abnormal FFMI (58.3 versus 52.3% predicted, p ¼ 0.08).
Then again, daily physical activity level has been shown
to be reduced in patients with COPD compared to healthy
age-matched subjects, irrespective of the degree of
pulmonary function impairment.29 Therefore, other under-lying factors may to some degree have contributed to FFM
depletion in a subgroup of COPD patients with MRC dyspnea
grade 1/2.31–33Exercise intolerance
In the present study, patients with MRC dyspnea grades 1/2
had the best 6MWD compared to patients with a higher MRC
dyspnea grade (Table 2, Figure 1). These findings are in line
with previous findings.9,34 These data suggest that func-
tional exercise capacity is related to the degree of severity
of dyspnea perceived during daily life. In fact, patients with
MRC dyspnea grade 4 or 5 had also the worst symptom Borg
scores for dyspnea at the end of the 6MWD. Furthermore,
the mean difference in 6MWD between patients with MRC
dyspnea grade 1/2 and grade 4 (112.7m) or grade 5
(141.9m) clearly exceeded the minimum clinically impor-
tant difference of 54m.35
COPD patients with MRC dyspnea grade 5 had the
worst peak exercise capacity of all MRC strata, as seen
previously.9 Nevertheless, a decreased mean peak exercise
capacity has been found in all MRC strata (Table 2). Indeed,
mean peak oxygen uptake of all MRC strata was clearly
below the lower limit of normal as proposed in the latest
statement on cardiopulmonary exercise testing by the
American Thoracic Society and the American College of
Chest Physicians (lower limit of normal for peak VO2: 85%
predicted).36
A clear difference has been observed between MRC strata
concerning peak heart rate and peak minute ventilation at
the end of the symptom-limited incremental exercise test
(Table 2). In fact, patients with MRC dyspnea grade 1/2
generally have been shown to have a cardio-circulatory
limitation, which makes them most probably good candi-
dates for an endurance-type of exercise training.6,19,37 In
contrast, patients with grade 4 or 5 were generally
ventilatory limited, which makes them most probably good
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exercise tolerance.38 The latter patients may even improve
their exercise tolerance by performing progressive resis-
tance training39 or transcutaneous neuromuscular electrical
stimulation.40
Mood status
Recently, the mean scores on the Brief Assessment Schedule
Depression Cards were not different between COPD patients
entering rehabilitation with MRC dyspnea grade 1/2, 3/4 or
5.9 On the contrary, higher HADS scores for anxiety and
depression have been reported in COPD patients entering
pulmonary rehabilitation with MRC dyspnea grade 5 com-
pared to lower grades.4 The latter finding has been
corroborated in the present study (Table 3). It seems
therefore reasonable to hypothesize that the presence of
anxiety and/or depression is, at least in part, related to the
perceived dyspnea during daily life in COPD. In fact, patients
with severe COPD had a 2.5 times greater risk for depression
than healthy control subjects.41 Moreover, dyspnea has
shown to be significantly related to depression in elderly
patients with recent hospitalization for acutely decompen-
sated heart failure.42
Disease-specific health status
Previously, male COPD outpatients with MRC dyspnea grade
2 have shown to have lower median total SGRQ scores
compared to patients with severe dyspnea (e.g. combination
of grades 3, 4 and 5).10 The present study is the first to
observe significant differences in SGRQ total scores between
all MRC strata in a large group of consecutive patients with
COPD (Table 3, Figure 2). In fact, mean differences in total
SGRQ scores between patients with MRC dyspnoea grade 1/2
and patients with grade 3, 4 or 5 were approximately a three
fold, four fold and six fold of the minimum clinically
important difference of 4 points, respectively.43 It is
therefore reasonable to conclude that dyspnea is a
strong determinant of disease-specific health status.44
However, patients who do not experience extreme dyspnea
during activities of daily life (e.g. MRC dyspnea grade 1/2)
appear to still have an increased ( ¼ worse) mean total
SGRQ score compared to values obtained in healthy
elderly.11,45 This is in line with Garrod and colleagues.9
These findings point strongly toward the fact that COPD
patients with MRC dyspnea grade 1/2 may still have a
reduced disease-specific health status. Therefore, other
factors besides dyspnea may, at least in part, also contribute
to a decreased disease-specific health status in patients with
COPD.14,46–52
Pulmonary rehabilitation
In the recent past, the MRC dyspnea scale has been
suggested and used to select COPD patients who may
benefit from rehabilitation.6 This suggestion has been
based on experts opinion that rehabilitation of patients
with COPD becomes appropriate when these patients
become aware of their disability, irrespective of their
pulmonary dysfunction.7 Actually, COPD patients with MRCgrade 1 or 2 have been excluded from a rehabilitation
program as being ‘too fit’.8 However, the present results
clearly indicate that COPD patients referred for rehabilita-
tion with MRC grade 1/2 may have extra-pulmonary
features, which most probably can be addressed during a
comprehensive interdisciplinary pulmonary rehabilitation
program.2,6,37,39,53,54 Indeed, Garrod and colleagues have
shown significant mean improvements in 6MWD (+55m)
and total SGRQ score (7.5 points) in COPD patients with
baseline MRC dyspnea grade 1/2 following 7 weeks of twice-
weekly outpatient exercise training and patient education.9
The latter improvements were comparable to those of
COPD patients with baseline MRC dyspea grade 3/4 and were
significantly better than those of COPD patients with
baseline MRC dyspnea grade 5.9 In addition, COPD
patients with somewhat ventilatory reserve during a base-
line symptom-limited incremental cycling test have been
shown to be the best responders during a 6-month
exercise training program.55 In the present study, this would
be the grade 1/2 patients (Table 2). Finally, healthy
elderly may also benefit from physical exercise training,
while they most probably will have a MRC dyspnea grade 1 at
baseline.56 Therefore, it appears reasonable to hypothesize
that the MRC dyspnea scale alone is not an ideal measure
to identify COPD patients who may benefit from rehabilita-
tion. Based on the present results, it may be reasonable
to add the bioelectrical impedance assessment. Indeed,
the MRC dyspnea scale (e.g. grade 3 or above) together
with the overnight fasting bioelectrical impedance
assessment (e.g. an abnormal low FFMI) identified
already 91% of the present patients entering pulmonary
rehabilitation.Limitations of the present study
Preferably, healthy controls should have been included in
the present study to demonstrate the presence of extra-
pulmonary features in COPD patients, in particular in those
with MRC dyspnea grade 1/2. Nevertheless, to determine
the presence of extra-pulmonary features in the present
COPD patients have been based on internationally well-
established cut-off values obtained in healthy age-matched
control subjects.
The presence of whole-body muscle mass depletion
may have been an important reason to refer COPD
patients with MRC dyspnea grade 1/2 for rehabilitation.
This, in turn, may have resulted in a selection bias.
However, the prevalence of cachexia in the present
COPD patients with MRC dyspnea grade 1/2 is in agreement
with findings in Dutch COPD outpatients with MRC
dyspnea grade 1/2 who volunteered to participate in the
COSMIC trial.57
Statistically significant differences between self-reported
MRC dyspnea grades need to be interpreted in the light of
the number of comparisons that were made in the present
study. Nonetheless, the current statistical procedures have
been used to test pre-defined hypotheses.
Finally, the present authors want to stress that they have
been using the original MRC dyspnea scale as done
before,4,5,8–10,40 while others have been using various
modifications of the MRC scale.28,58–63 Although the
different versions of the MRC dyspnea scales are rather
ARTICLE IN PRESS
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scoring is slightly different and may therefore be somewhat
misleading.
Conclusions
At present, the MRC dyspnea scale does provide an
indication of the degree of severity concerning
extra-pulmonary features in patients with moderate to
severe COPD entering rehabilitation. Nevertheless, the
MRC dyspnea scale is inadequate to identify extra-
pulmonary features in the clinical practice in individual
patients with COPD. Therefore, MRC dyspnea scale
alone does not appear to be a suitable measure to
identify most patients with COPD who have to be
referred for rehabilitation. Future studies are warranted
to determine whether chest physicians can use the
MRC dyspnea scale and the overnight fasting bioelectri-
cal impedance assessment together to identify COPD
patients at the outpatient consultation for pulmonary
rehabilitation.
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